The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(100)

Putting patients first: from buzzword to business imperative (Sponsored)

Putting patients first: from buzzword to business imperative (Sponsored)

What does it really mean to put patients first in today’s life sciences landscape? In this sponsored episode of The Top Line, leaders from RTI Health Solutions explore how patient voices are transform...

12 Tammi 28min

Beyond the AI hype: How life sciences can turn agents into a competitive advantage (Sponsored)

Beyond the AI hype: How life sciences can turn agents into a competitive advantage (Sponsored)

As artificial intelligence continues to dominate conversations across life sciences, many companies are reaching an inflection point between experimentation and real-world impact. In a recent episode ...

12 Tammi 19min

China’s biotech moment goes global, Zai Lab exec says (Sponsored)

China’s biotech moment goes global, Zai Lab exec says (Sponsored)

China has moved from a fast-following biotech market to a source of globally competitive innovation, according to Josh Smiley, president and chief operating officer of Zai Lab. Speaking on The Top Lin...

12 Tammi 23min

Biopharma CEOs assess the road ahead in 2026

Biopharma CEOs assess the road ahead in 2026

After a turbulent 2025, the biopharma industry is heading into the new year with major questions still unresolved. A tough biotech investing environment, aggressive direct-to-consumer drug marketing a...

9 Tammi 20min

A year in review and what 2026 holds for biopharma and healthcare

A year in review and what 2026 holds for biopharma and healthcare

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research ...

19 Joulu 20251h 14min

From data to decisions: how Walgreens is powering smarter pharma strategies (Sponsored)

From data to decisions: how Walgreens is powering smarter pharma strategies (Sponsored)

Walgreens is emerging as a real-world evidence partner for the biopharma industry, according to a new episode of The Top Line, sponsored by Walgreens. In the conversation, Deepak Kuletha, who leads da...

8 Joulu 202513min

The biopharma dealmaking landscape and what to expect in 2026

The biopharma dealmaking landscape and what to expect in 2026

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and slash prescription drug prices. But as players in the biopharma industry have ...

5 Joulu 202525min

Advocacy, access and the future of cancer care take center stage in new Health Matters episode (Sponsored)

Advocacy, access and the future of cancer care take center stage in new Health Matters episode (Sponsored)

In this episode of Health Matters, GCI Health’s Ryan Kuresman and Health@WPP’s Wendy Lund explore the fast-shifting landscape of cancer care with Pam Traxel of the American Cancer Society Cancer Actio...

1 Joulu 202523min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
vallattomat
aikalisa
politiikan-puskaradio
rss-viihde-media
rss-ootsa-kuullut-tasta
ootsa-kuullut-tasta-2
rss-vaalirankkurit-podcast
rss-voi-venaja
the-ulkopolitist
tervo-halme
otetaan-yhdet
rss-asiastudio
rss-kaikki-uusiksi
rss-vihrea-tuuma
rss-toisten-taskuilla
rss-ulkopoditiikkaa
rss-raha-talous-ja-politiikka
rss-girls-finish-f1rst
rss-podme-livebox